Safer Aging With Diabetes Monitoring

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75+
SponsorKaiser Permanente

About this trial

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Eligibility criteria

Qualifiers

Age 75 years and older

Diagnosis of Type 2 Diabetes

Current treatment with insulin

Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)

Disqualifiers

On renal dialysis

Dementia

Pacemaker or Automatic Implantable Cardioverter Defibrillator

Using insulin pump

Trial design

Treatments tested in this trial

  • SAGE Group Sessions
  • Usual Care

Treatment groups

360 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Kaiser Permanente

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator